Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Psychopharmacology : straight talk on mental health medications / / Joe Wegmann
| Psychopharmacology : straight talk on mental health medications / / Joe Wegmann |
| Autore | Wegmann Joseph |
| Edizione | [4th ed.] |
| Pubbl/distr/stampa | Eau Claire, Wisconsin : , : PESI Publishing, , [2021] |
| Descrizione fisica | 1 online resource (335 pages) |
| Disciplina | 616.8914 |
| Soggetto topico | Psychotherapy |
| ISBN | 1-68373-350-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Copyright -- The Author -- Table of Contents -- Acknowledgments -- Introduction: What's Inside -- Section One: Getting Started with The Client -- Chapter 1: The DSM® -- Medical Model -- Neurobiology -- Chapter 2: The First Visits with the Client -- Section Two: Clinical Syndromes -- Chapter 3: Schizophrenia and Other Psychotic Spectrum Disorders -- Chapter 4: Depression -- Chapter 5: Bipolar Disorder -- Chapter 6: The Many Manifestations of Anxiety -- Chapter 7: Opiates, Opioids and Medical Marijuana -- Section Three: Treatment -- Chapter 8: Antipsychotics -- Dosage Range Chart-Antipsychotic Medications -- Chapter 9: Antidepressants: -- Dosage Range Chart-Antidepressants -- Chapter 10: Treatment-Resistant Depression -- Chapter 11: Other Treatment Paths for Managing Depression -- Chapter 12: Mood-Stabilizing Agents -- Dosage Range Chart-Mood Stabilizers, Anticonvulsants -- Chapter 13: Antianxiety Medications, Sleep Agents -- Dosage Range Chart-Antianxiety Medications, Sleep Agents -- Chapter 14: Anxiety and Insomnia: Treatment Beyond Medication -- Chapter 15: Treatment of Opiate and Opioid Disorders -- Chapter 16: Chronic Pain Management -- Section Four: Specific Populations, ADHD, Herbals & -- Supplements, Solving Medication Challenges -- Chapter 17: Specific Population Groups -- Chapter 18: Attention Deficit Hyperactivity Disorder -- Dosage Range Chart-Antianxiety Medications, Sleep Agents -- Chapter 19: Herbals and Supplements -- Chapter 20: Solving Medication Challenges -- Chapter 21: Psychopharmacology Going Forward -- Conclusion -- Appendices -- Appendix I: Making a Medication Referral -- Appendix II: Frequently Asked Questions -- Appendix III: Medication Noncompliance and How Healthcare Professionals Can Help -- Appendix IV: Are All Drugs Created Equal? Brand Name vs. Generic Medications -- Appendix V: The Placebo Effect.
Appendix VI: Tapering and Discontinuing Psychotropic Medication -- Appendix VII: Pharmacogenetic Testing in Psychiatry -- Appendix VIII: Talking to Clients About Psychotropic Medication Side Effects -- Appendix IX: Tele-Treatment -- Appendix X: Master Drug Chart -- References -- Resource Websites -- Index. |
| Record Nr. | UNINA-9910794793703321 |
Wegmann Joseph
|
||
| Eau Claire, Wisconsin : , : PESI Publishing, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Psychopharmacology : straight talk on mental health medications / / Joe Wegmann
| Psychopharmacology : straight talk on mental health medications / / Joe Wegmann |
| Autore | Wegmann Joseph |
| Edizione | [4th ed.] |
| Pubbl/distr/stampa | Eau Claire, Wisconsin : , : PESI Publishing, , [2021] |
| Descrizione fisica | 1 online resource (335 pages) |
| Disciplina | 616.8914 |
| Soggetto topico | Psychotherapy |
| ISBN | 1-68373-350-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Copyright -- The Author -- Table of Contents -- Acknowledgments -- Introduction: What's Inside -- Section One: Getting Started with The Client -- Chapter 1: The DSM® -- Medical Model -- Neurobiology -- Chapter 2: The First Visits with the Client -- Section Two: Clinical Syndromes -- Chapter 3: Schizophrenia and Other Psychotic Spectrum Disorders -- Chapter 4: Depression -- Chapter 5: Bipolar Disorder -- Chapter 6: The Many Manifestations of Anxiety -- Chapter 7: Opiates, Opioids and Medical Marijuana -- Section Three: Treatment -- Chapter 8: Antipsychotics -- Dosage Range Chart-Antipsychotic Medications -- Chapter 9: Antidepressants: -- Dosage Range Chart-Antidepressants -- Chapter 10: Treatment-Resistant Depression -- Chapter 11: Other Treatment Paths for Managing Depression -- Chapter 12: Mood-Stabilizing Agents -- Dosage Range Chart-Mood Stabilizers, Anticonvulsants -- Chapter 13: Antianxiety Medications, Sleep Agents -- Dosage Range Chart-Antianxiety Medications, Sleep Agents -- Chapter 14: Anxiety and Insomnia: Treatment Beyond Medication -- Chapter 15: Treatment of Opiate and Opioid Disorders -- Chapter 16: Chronic Pain Management -- Section Four: Specific Populations, ADHD, Herbals & -- Supplements, Solving Medication Challenges -- Chapter 17: Specific Population Groups -- Chapter 18: Attention Deficit Hyperactivity Disorder -- Dosage Range Chart-Antianxiety Medications, Sleep Agents -- Chapter 19: Herbals and Supplements -- Chapter 20: Solving Medication Challenges -- Chapter 21: Psychopharmacology Going Forward -- Conclusion -- Appendices -- Appendix I: Making a Medication Referral -- Appendix II: Frequently Asked Questions -- Appendix III: Medication Noncompliance and How Healthcare Professionals Can Help -- Appendix IV: Are All Drugs Created Equal? Brand Name vs. Generic Medications -- Appendix V: The Placebo Effect.
Appendix VI: Tapering and Discontinuing Psychotropic Medication -- Appendix VII: Pharmacogenetic Testing in Psychiatry -- Appendix VIII: Talking to Clients About Psychotropic Medication Side Effects -- Appendix IX: Tele-Treatment -- Appendix X: Master Drug Chart -- References -- Resource Websites -- Index. |
| Record Nr. | UNINA-9910809675403321 |
|
Wegmann Joseph
|
||
| Eau Claire, Wisconsin : , : PESI Publishing, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||